Related Experiment Video
Updated: Jun 3, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Report of a joint ESOT and AST meeting: highlights in biologic agents and transplantation
1Erasmus MC, Department of Internal Medicine, Rotterdam, The Netherlands.
A joint meeting organized by the European (ESOT) and American (AST) Societies of Transplantation occurred in Nice, France, October 1-3, 2010. Focused on emerging use of biologic agents in solid organ transplantation, it served as a venue for state-of-the-art updates in basic immunology and clinical science, with an emphasis on the interrelatedness of the two. This meeting summary is designed to highlight important insights communicated in Nice, offer an overview of novel therapeutics in development, and entice members of all societies to consider attending a second joint symposium, under consideration for 2012.
A joint meeting organized by the European (ESOT) and American (AST) Societies of Transplantation occurred in Nice, France, October 1-3, 2010. Focused on emerging use of biologic agents in solid organ transplantation, it served as a venue for state-of-the-art updates in basic immunology and clinical science, with an emphasis on the interrelatedness of the two. This meeting summary is designed to highlight important insights communicated in Nice, offer an overview of novel therapeutics in development, and entice members of all societies to consider attending a second joint symposium, under consideration for 2012.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Kidney Transplant I: Introduction
Drug Products: Biologics, Biosimilars and Interchangeables
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

